Breast Cancer Reveals Latent BMPR2 -Related Susceptibility to Pulmonary Hypertension
Authors:
- Victoria ToroVTVictoria Toro
- Manon MouginMMManon Mougin
- Coline BrossatCBColine Brossat
- Clement Jambon-BarbaraCJClement Jambon-Barbara
- Alex HlavatyAHAlex Hlavaty
- Charles Antoine GuayCGCharles Antoine Guay
- Reem El KabboutRKReem El Kabbout
- Coralie BilodeauCBCoralie Bilodeau
- Yann GrobsYGYann Grobs
- Sandra MartineauSMSandra Martineau
- Sandra Breuils-BonnetSBSandra Breuils-Bonnet
- Antonella Abi-SleimenAAAntonella Abi-Sleimen
Open Access
- 17 February 2026
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (7) , 516-533
Abstract
BACKGROUND: Pulmonary arterial hypertension (PAH) and breast cancer disproportionately affect women. BMPR2 (bone morphogenetic protein receptor type 2) mutations, the most common genetic cause of heritable PAH, also exert tumor-suppressive functions, but their role in linking these diseases remains unclear. METHODS: We combined bioinformatic, epidemiologic, and experimental approaches. Public cancer datasets were mined for BMPR2 alterations. In vivo, mammary tumor development and pulmonary hemodynamics were assessed in female Bmpr2 +/Δ71 rats with or without carcinogen (7,12-dimethylbenz[a]anthracene) exposure. Pulmonary arterial smooth muscle cells were exposed to tumor-conditioned media to test inflammatory proliferation. Finally, associations between breast cancer and PAH were examined in the French National Healthcare Database (9964 patients with PAH). RESULTS: BMPR2 expression was markedly reduced in human breast tumors, with recurrent somatic variants and deep deletions identified. Bmpr2 +/Δ71 rats exhibited spontaneous mammary tumors and, following 7,12-dimethylbenz[a]anthracene exposure, developed exacerbated pulmonary hypertension with increased vascular remodeling and inflammation. Tumor-bearing Bmpr2 +/Δ71 rats showed elevated lung IL-1β and NF-κB activation. In vitro, conditioned media from Bmpr2 +/Δ71 tumors induced proliferation of Bmpr2 +/Δ71 pulmonary arterial smooth muscle cells via IL-1β–dependent signaling, while neutralization of IL-1β attenuated this effect. Human pulmonary arterial smooth muscle cells carrying BMPR2 mutations similarly displayed heightened IL-1β–induced proliferation. Epidemiologically, breast cancer incidence was more than doubled in patients with PAH compared with the general population, and PAH incidence was increased nearly 9-fold among patients with breast cancer, indicating a bidirectional relationship. CONCLUSIONS: These findings identify a reciprocal association between breast cancer and PAH mediated by defective BMPR2 signaling and tumor-associated inflammation. Breast cancer may act as a “second hit,” unmasking BMPR2 -related susceptibility to PAH, underscoring BMPR2 as a shared molecular vulnerability with implications for surveillance of at-risk populations.Keywords
This publication has 62 references indexed in Scilit:
- Association of Pulmonary Hypertension With Trastuzumab EmtansineChest, 2024
- Pulmonary hypertension is associated with an increased incidence of cancer diagnosesPulmonary Circulation, 2022
- Isolation, culture and identification of pulmonary arterial smooth muscle cells from rat distal pulmonary arteriesCytotechnology, 2017
- Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2Biochemical Pharmacology, 2015
- BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary HypertensionCell Metabolism, 2015
- Chemotherapy-Induced Pulmonary HypertensionThe American Journal of Pathology, 2015
- An international comparison of male and female breast cancer incidence ratesInternational Journal of Cancer, 2012
- Penetrance of pulmonary arterial hypertension is modulated by the expression of normalBMPR2alleleHuman Mutation, 2009
- Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growthBiochemical and Biophysical Research Communications, 2007
- Pulmonary tumor thrombotic microangiopathy with pulmonary hypertensionCancer, 1990